← All stocks

CG Oncology, Inc.

CGON Net buying
CIK 0001991792 #1141 in the set updated 17 Sep 2026
Bought (12 mo)
$24.81M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$6.59M
$0.00 on a plan · $6.59M straight out of an exercise
Sold at will
$0.00
0 of 20 sales
Net
+$18.23M
+$24.81M against sales at will

By person

5 insiders · 23 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Liu Brian Guan-Chyun
Director
$24.81M (1)
+$24.81M
1,886,236
2.13%
$140.60M
Mulay James
Director
$5.43M (12) scheduled
−$5.43M
0
0.0000%
$0.00
POST LEONARD E
Director
$1.16M (8) scheduled
−$1.16M
0
0.0000%
$0.00
Song Hong Fang
Director
2,903,931
3.28%
$216.46M
−21.6%
Kuan Arthur
Chief Executive Officer
198,916
0.2244%
$14.83M
+450.2%
Insider
Date
Role
Action
Shares
Price
Amount
POST LEONARD E
14 Aug 2026
Director
Sold after exercise
1,000
$74.54
$74.54K
POST LEONARD E
15 Jul 2026
Director
Sold after exercise
1,000
$71.17
$71.17K
Mulay James
10 Jul 2026
Director
Sold after exercise
24,165
$75.16
$1.82M
POST LEONARD E
24 Jun 2026
Director
Sold after exercise
5,000
$70.00
$350.00K
POST LEONARD E
22 Jun 2026
Director
Sold after exercise
5,000
$65.00
$325.00K
Mulay James
15 Jun 2026
Director
Sold after exercise
1,310
$60.12
$78.76K
Mulay James
15 Jun 2026
Director
Sold after exercise
654
$60.12
$39.32K
POST LEONARD E
4 Jun 2026
Director
Sold after exercise
1,000
$54.50
$54.50K
Mulay James
17 Apr 2026
Director
Sold after exercise
15,600
$73.01
$1.14M
Mulay James
16 Mar 2026
Director
Sold after exercise
1,310
$63.50
$83.19K
Mulay James
16 Mar 2026
Director
Sold after exercise
654
$63.50
$41.53K
Mulay James
9 Jan 2026
Director
Sold after exercise
10,491
$52.99
$555.92K
Mulay James
9 Jan 2026
Director
Sold after exercise
654
$44.16
$28.88K
POST LEONARD E
17 Nov 2025
Director
Sold after exercise
1,000
$41.43
$41.43K
POST LEONARD E
13 Oct 2025
Director
Sold after exercise
1,000
$43.25
$43.25K
Mulay James
9 Oct 2025
Director
Sold after exercise
5,903
$43.99
$259.67K
POST LEONARD E
30 Sep 2025
Director
Sold after exercise
5,000
$40.09
$200.45K
Mulay James
29 Sep 2025
Director
Sold after exercise
12,755
$39.19
$499.87K
Mulay James
19 Sep 2025
Director
Sold after exercise
3,574
$38.99
$139.35K
Mulay James
18 Sep 2025
Director
Sold after exercise
19,112
$39.01
$745.56K

What was left out

Form 4 filings counted 30
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 20
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 288,383
History held since 26 Jan 2024